<scp>ForePass</scp> outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine
Sara Russo(Università Cattolica del Sacro Cuore), Geltrude Mingrone(University of the Sacred Heart), Carel W. le Roux(University College Dublin), Elena Previti(Università Cattolica del Sacro Cuore), Sara Roggiani(University of Bologna), Fabrizia Carli(Istituto di Fisiologia Clinica), Maria Emiliana Caristo(Università Cattolica del Sacro Cuore), Ivo Boškoski(Università Cattolica del Sacro Cuore), Stefan R. Bornstein(King's College London), Manoel Galvão Neto(Orlando Health), Amalia Gastaldelli(National Research Council), Rima Chakaroun(Sahlgrenska University Hospital), Vincenzo Bove(Agostino Gemelli University Polyclinic), Giulia Angelini(Università Cattolica del Sacro Cuore), Valentina Tremaroli(University of Gothenburg), Luca Proto(Agostino Gemelli University Polyclinic), Samantha Pezzica(Istituto di Fisiologia Clinica)
Cited by 1
Related Papers
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
|New England Journal of Medicine|2015|2.6k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|1.7k